Apoptosis requires the transmission of apoptotic signals from the plasma membrane receptors to caspases. In receptor-mediated apoptosis, apoptotic initiation is due to the formation of a protein-signaling complex that involves the physical association of caspases followed by their activation (1, 2). Fas, a member of tumor necrosis factor receptor superfamily, has an intracellular death domain (DD) 1 in its cytoplasmic region (3-6). The DD is essential for the transduction of apoptotic signal. The Fas-associated death domain protein (FADD) binds to the DD of Fas through its DD in the C terminus (7, 8) . In addition to DD, FADD has a DED at its N terminus, another protein interaction module. Therefore, FADD can recruit caspase-8 to the DISC by homotypic interactions between the DEDs of FADD and caspase-8 (2, 9). The Fas-DISC formation is the first event that occurs during Fas-initiated cell death signaling. Following Fas-DISC formation, caspase-8 subsequently can be activated by autocleavage leading to the release of the active subunits p18 and p10 (2, 10). In addition, the activated caspase-8 activates downstream effector caspases such as caspase-3, caspase-6, and caspase-7 (11-16). In addition to FADD and caspase-8, another DED-containing protein related to DISC has been reported. Viral FLICE inhibitory protein (v-FLIP) is composed of two DEDs and binds to the Fas⅐FADD complex and inhibits the recruitment of caspase-8 to Fas-DISC. A human homolog of v-FLIP has many different names c-FLIP, FLAME, I-FLICE, Casper, CASH, usurpin, MRIT, and CLARP, respectively (17-24). FLICE-associated huge protein (FLASH) is another protein with binding activity to the DEDs of caspase-8 and FADD through its DEDlike domain and is a component of the Fas-DISC (25). In addition, FLASH enhances the activation of caspase-8 in Fas-mediated apoptosis. Thus, DED-containing proteins seem to modulate the apoptotic process.
Apoptosis requires the transmission of apoptotic signals from the plasma membrane receptors to caspases. In receptor-mediated apoptosis, apoptotic initiation is due to the formation of a protein-signaling complex that involves the physical association of caspases followed by their activation (1, 2) . Fas, a member of tumor necrosis factor receptor superfamily, has an intracellular death domain (DD) 1 in its cytoplasmic region (3) (4) (5) (6) . The DD is essential for the transduction of apoptotic signal. The Fas-associated death domain protein (FADD) binds to the DD of Fas through its DD in the C terminus (7, 8) . In addition to DD, FADD has a DED at its N terminus, another protein interaction module. Therefore, FADD can recruit caspase-8 to the DISC by homotypic interactions between the DEDs of FADD and caspase-8 (2, 9) . The Fas-DISC formation is the first event that occurs during Fas-initiated cell death signaling. Following Fas-DISC formation, caspase-8 subsequently can be activated by autocleavage leading to the release of the active subunits p18 and p10 (2, 10) . In addition, the activated caspase-8 activates downstream effector caspases such as caspase-3, caspase-6, and caspase-7 (11) (12) (13) (14) (15) (16) . In addition to FADD and caspase-8, another DED-containing protein related to DISC has been reported. Viral FLICE inhibitory protein (v-FLIP) is composed of two DEDs and binds to the Fas⅐FADD complex and inhibits the recruitment of caspase-8 to Fas-DISC. A human homolog of v-FLIP has many different names c-FLIP, FLAME, I-FLICE, Casper, CASH, usurpin, MRIT, and CLARP, respectively (17) (18) (19) (20) (21) (22) (23) (24) . FLICE-associated huge protein (FLASH) is another protein with binding activity to the DEDs of caspase-8 and FADD through its DEDlike domain and is a component of the Fas-DISC (25) . In addition, FLASH enhances the activation of caspase-8 in Fas-mediated apoptosis. Thus, DED-containing proteins seem to modulate the apoptotic process.
Two different cell types in Fas signaling pathways have been identified (26) . Type I cells are characterized by recruitment of caspase-8 to the DISC following Fas activation, leading to direct activation of downstream caspases, including caspase-3 and caspase-7. In type I cells, the blocking of mitochondrial apoptotic function by overexpression of Bcl-2 has no effect on caspase activation. In type II cells, the amount of active caspase-8 generated in the DISC is low. In addition, DISC formation in type II cells is strongly reduced, and overexpression of Bcl-2 or Bcl-X L blocks caspase-8 and caspase-3 activation. Thus, Fas-mediated apoptosis in type II cells is dependent on mitochondrial activity.
FAF1 is a Fas-associating molecule, which enhances Fasmediated apoptosis (27) . In our previous work, mere intrinsic overexpression of FAF1 initiated apoptosis in the absence of extrinsic death signals in BOSC23 cells (28) . This apoptotic potential required the region comprising amino acids 181-381 of FAF1. Mouse FAF1 (mFAF1), however, was able to enhance but unable to initiate apoptosis in L-cells (27) . Thus, the apoptotic potential of FAF1 is not clear. The N terminus of FAF1 binds to the DD of Fas even though it does not contain the typical death domain (29) . Although FAF1 contains domains found in the proteins of ubiquitination pathway, the function of FAF1 in relation to ubiquitin is largely unknown. FAF1 localizes in the nucleus, the perinuclear cytoplasm, and the nucleoli depending on the cell type (28, 30, 31) . FAF1 is not only a binding partner of protein kinase CK2 but also a substrate target for serine residues 289 and 291 (31, 32) . Also, the interaction of protein kinase CK2 and FAF1 is enhanced in vivo upon induction of apoptosis (33) .
In this study, we demonstrate that FAF1 is a component of Fas-DISC, and DISC is formed by interaction of the DED-like region (amino acid 181-381 of FAF1) of FAF1 and the DEDs of caspase-8 and FADD. Therefore, this study provides a molecular explanation regarding the proapoptotic role of FAF1 in Fas-mediated signaling.
EXPERIMENTAL PROCEDURES
Materials and Reagents-For confocal microscopy, antibodies against FAF1 (M-20), Fas (C-20), FADD (N-18), caspase-8 (N-19), and PARP (F-2) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against FITC-conjugated goat anti-rabbit and rabbit anti-goat, and TRITC-conjugated rabbit anti-goat were purchased from Sigma (St. Louis, MO). For Western analysis, antibodies against FADD (A66 -2) and caspase-8 (IC12) were purchased from Transduction Laboratories (Lexington, KY) and Cell Signaling Technology (Beverly, MA), respectively. FAF1 monoclonal antibody was a gift from Dr. J. S. Lim (Korea Research Institute of Bioscience and Biotechnology, Korea). For stimulation of Fas, antibody against Fas (CH-11) was purchased from Upstate Biotechnology (Lake Placid, NY). For immunoprecipitation of DISC, antibody against Fas (APO-1) kindly provided by Dr. P. H. Krammer (German Cancer Research Center, Heidelberg, Germany) was used. Horseradish peroxidase-conjugated secondary antibodies were purchased from Sigma. The glutathione beads and Ni 2ϩ -nitrilotriacetic acid beads were purchased from Peptron (Daejeon, Korea) and Qiagen (Heidelberg, Germany), respectively. The protein A/G-agarose beads were purchased from Santa Cruz Biotechnology. All restriction enzymes were purchased from TaKaRa Shuzo Co. (Shiga, Japan).
Plasmids-Construction of the HA-tagged FADD, GST-fused FAF1, GFP-tagged FAF1, pcDNA3/FAF1, FLAG-tagged FAF1, and FLAGtagged FAF1-(181-650), which where named to FAF1-⌬FID, was reported previously (28, 29, 34) . FLAG-tagged FAF1-(366 -650) was cloned by PCR using FLAG-tagged FAF1 as a template and named to FAF1-⌬FID⅐DEDID. pcDNA3/FAF1-⌬DEDID was generated by PCR using the pJG4 -5/FAF1(s) (29) . FAF1(s) is an endogenous isoform of FAF1 with an internal in-frame deletion that overlaps most of the DEDID (FAF1-DEDID corresponds to amino acids 181-381 of FAF1, and amino acids 188 -339 of FAF1 is deleted in FAF1(s)). The construction of His-tagged caspase-8 (pET21b/caspase-8) and His-tagged caspase-8C (pET21b/caspase-8C) was reported previously (35) . To clone the FAF1 deletion mutants (FAF1-(1-305), FAF1-⌬FID, and FAF1-DEDID) into glutathione S-transferase (GST) fusion vector (Amersham Biosciences, Uppsala, Sweden), PCRs with primers containing EcoRI and XhoI linkers were performed using GST-FAF1 full-length cDNA as a template. The pcDNA3/caspase-8 DED construct was generated by PCR using the PET21b/caspase-8 plasmid as a template with primers containing HindIII and BamHI linkers. To subclone the FADD and its deletion mutants (FADD-DD and FADD-DED) into GST fusion vector, PCRs were performed using pcDNA3/FADD plasmid as a template. pcDNA3.1/FADD-DED was kindly provided by Dr. S. H. Kim (Seoul National University, Korea).
In Vitro Protein Binding-GST fusion proteins were expressed in Escherichia coli BL21(DE3) with isopropyl-␤-D-thiogalactopyranoside induction. Subsequently, cells were sonicated in ice-cold lysis buffer (200 mM Tris-Cl, pH 8.0, 0.5 M NaCl, 100 M EDTA, 0.1% Triton X-100, 0.4 mM phenylmethylsulfonyl fluoride). The GST fusion proteins were incubated with glutathione-coated beads for 4 h at 4°C and normalized for protein concentration. The pcDNA3/FAF1, pcDNA3/FADD, pET21b/caspase-8, pET21b/caspase-8C, and pcDNA3/caspase-8 DED were translated in vitro with TNT Quick Coupled Transcription/Translation Systems (Promega, Madison, WI). Briefly, 2 g of DNA was incubated with 20 Ci of [ 35 S]methionine in the TNT Quick Master mix for 90 min at 30°C. In vitro translated products were mixed with GST-fused proteins bound onto glutathione-coated beads in the binding buffer (50 mM Hepes, pH 7.6, 50 mM NaCl, 5 mM EDTA, 0.1% Nonidet P-40, 10% glycerol) and then incubated for 4 h at 4°C. After washing three times in the lysis buffer, samples were treated with SDS-loading buffer containing 5% ␤-mercaptoethanol. The samples were loaded onto an SDS-PAGE gel and visualized by using a BAS analyzer (Fuji Photo Film Co., Tokyo, Japan).
Cell Culture-Jurkat cells were all maintained in RPMI 1640 (Jeil Biotechservices Inc., Daegu, Korea), antibiotic-antimycotic (100 units/ml penicillin G sodium, 100 g/ml streptomycin sulfate, and 0.25 g/ml amphotericin B) (Invitrogen, Grand Island, NY) and 10% fetal calf serum (Invitrogen) in 5% CO 2 . For immunoprecipitation assay using anti-FADD antibody (N-18), anti-FAF1 monoclonal antibody, and control antibody, IgG1, (BD Biosciences, San Jose, CA), 1 ϫ 10 7 Jurkat cells were cultured and serum-starved with RPMI 1640 medium without fetal bovine serum for 12 h. Cells were harvested at 1 h after 50 ng/ml anti-Fas (CH-11) antibody treatment together with 5 g/ml cycloheximide (CHX) and lysed. The antibodies and protein A/G-Sepharose beads were added to the samples and incubated for 2 h at 4°C. The beads were washed four times with lysis buffer and subjected to either SDS-PAGE or immunoblotting.
Western Blotting-Samples were separated by SDS-PAGE and transferred onto a nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany) using an electrotransporter (OWL, Portsmouth, PA). Membranes were blocked for 1 h in Tris-buffered saline containing 0.05% Tween 20, 2 mM CaCl 2 dihydrate, 0.01% antifoam A, and 5% milk powder. After incubation at 4°C with anti-FADD (A66 -2), anti-FAF1 monoclonal, or anti-caspase-8 (IC12) antibodies, membranes were washed in Tris-buffered saline containing 0.05% Tween 20, 2 mM CaCl 2 dihydrate, 0.01% antifoam A, and 5% milk powder. Membranes were incubated with 1:2000 dilutions of horseradish peroxidase-conjugated secondary antibodies. Membrane were washed and developed with ECL plus Western blotting detection reagents (Amersham Biosciences, Uppsala, Sweden).
DISC Immunoprecipitation-1 ϫ 10 7 Jurkat cells were cultured for 24 h at 37°C in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics. After 24 h, the culture medium was exchanged with serum-free RPMI 1640 medium containing antibiotics and cultured for 12 h. After 12 h, cells were harvested at different times after anti-Fas antibody (50 ng/ml) treatment together with 5 g/ml CHX and lysed in Triton X-100 lysis buffer. As a control, anti-Fas antibody was added to lysates prepared from the unstimulated cells. Lysate protein content was determined by Bradford assay and equalized prior to immunoprecipitation. The anti-Fas (APO-1) and protein A/G-Sepharose beads were added to the samples and incubated for 2 h at 4°C. The beads were washed four times with lysis buffer and subjected to either SDS-PAGE or immunoblotting.
Cell Death Assay-Jurkat cells were transfected using either LipofectAMINE reagent (Invitrogen, Scotland, UK) or Nucleofactor TM solution provided by using an Amaxa apparatus (Amaxa, Cologne, Germany). For using the Amaxa system, 5 ϫ 10 6 Jurkat cells were harvested, washed once in PBS buffer, and resuspended in 100 l of specified electroporation buffer. Then, 1 g of plasmid DNA was mixed, transferred to a cuvette, and nucleofected with an Amaxa Nucleofector TM apparatus. After 30 h, cells were treated with 50 ng/ml anti-Fas antibody for 1 h. Cells were fixed in 3.7% formaldehyde for 15 min and mounted on slides using xylene substitute mountant/histomount solution, stained with 4Ј,6-diamidino-2-phenylindole, dihydrochloride (Molecular Probes, Eugene, OR), and analyzed by microscopy. For using LipofectAMINE reagent, 5 ϫ 10 6 cells of three different types of Jurkat cells (A3; parental, I2.1; FADD (Ϫ/Ϫ), and I9 -2; caspase-8 (Ϫ/Ϫ)) (36) were transiently transfected with GFP-tagged FAF1 using LipofectAMINE reagent. Cells were fixed and mounted on the slides as above. The percentage of apoptotic cells was analyzed based on the morphological change of cells under a fluorescence microscope. Excitation and emission wavelengths for GFP were 488 and 505 nm, respectively. Existence of GFP-FAF1, caspase-8, and FADD was assessed by immunoblot analysis.
Indirect Immunofluorescence-For localization analysis of Fas and FAF1, Jurkat cells with or without stimulation of Fas together with CHX were plated on a poly(A)-lysine-coated coverglass. They were fixed and rinsed with 1ϫ PBS containing 10% normal serum (Sigma). Therefore, we questioned if FAF1 was a component of the death-inducing signaling complex assembled with Fas (Fas-DISC). We first analyzed the binding pattern of FAF1 with Fas-DISC components. In vitro protein-protein binding assays were carried out by GST-pull-down using GST-fused FAF1, in vitro translated FADD, and caspase-8. As shown in Fig. 1A , in vitro translations of FADD and caspase-8 gave rise to 27-and 55-kDa 35 S-labeled proteins, respectively. Also, recombinant GST-FAF1 and GST proteins were produced in E. coli BL21(DE3) strain as 100-and 26-kDa proteins, respectively. In vitro translated FADD and caspase-8 were retained on matrices to which GST-FAF1 had bound but not GST only (Fig. 1A) . Thus, interactions between FAF1 and Fas-DISC members were demonstrated in the in vitro binding assay.
FAF1 Interacts with FADD and Caspase-8 in Jurkat
Cells-To show that FAF1 interacts with FADD and caspase-8 in mammalian cells, endogenous FAF1 and FADD were immunoprecipitated by the anti-FAF1 monoclonal antibody and the anti-FADD (N-18) antibody, respectively. The immunoprecipitates were analyzed by Western blot using antibodies against caspase-8 and FADD, respectively. As shown in Fig. 1B , each Fas-DISC member was detected in the immunoprecipitates, whereas it was not detected in the isotype control, IgG immunoprecipitates. Thus, the interaction of Fas-DISC components and FAF1 was demonstrated in vitro and in vivo, and these results show direct association of FAF1 with DISC members.
The Apoptotic Effector Domain (Amino Acids 181-381) of FAF1 Binds to the DED Domains of FADD and Caspase-8 -
Based on the fact that Fas-DISC complex is formed by interactions between their protein domains, we investigated which FAF1 domains were required for the binding to the Fas-DISC members. To map the binding domains to Fas-DISC proteins, an in vitro binding assay was performed using various deletion constructs (Figs. 1, C-F, and 2A ). As shown in Fig. 1 (C and D) , GST-FAF1-(181-381), corresponding to the previously known apoptotic effector domain (28) , was sufficient to interact with in vitro translated FADD (Fig. 1C) . The in vitro translated FAF1 was sufficient to bind to GST-FADD-DED but not to GST-FADD-DD (Fig. 1D) . In binding analysis between FAF1 and caspase-8, GST-FAF1-(181-381) was also mapped as the caspase-8 interacting region (Fig. 1E) . Among deletion constructs of caspase-8, the DED of caspase-8 was sufficient to bind to FAF1 but not to the C terminus of caspase-8 where the catalytic activity resides (Fig. 1F) . The N terminus (amino acids 1-201) of FAF1 was previously mapped as the binding site of Fas (29) . Thus, our data show that FAF1 has Fas-and caspase-8-interacting domains in tandem like FADD.
The DED-interacting Domain of FAF1-(181-381) Contains Several Helices-As shown above, the region of amino acids 181-381 of FAF1 was mapped as the interacting domain with the DED domains of FADD and caspase-8 (Figs. 1, C-F, and  2A) . Thus, we investigated whether the region of amino acids 181-381 of FAF1 has sequence similarities to the DED domains of FADD and caspase-8. Structure-based alignment analysis of FAF1 revealed that the amino acid similarity of the conventional DED domains to FAF1-(181-381) was not significant (Fig. 2B) . In addition, the consensus amino acid residues (RXDL) found in the DEDs (37) were not conserved in FAF1-(181-381). Thus, FAF1-(181-381) is named as DEDID (DEDinteracting domain) henceforth. The secondary structure analysis of FAF1-(181-381) with protein data base (www2. protein.Osaka-u.ac.jp) revealed that FAF1-(181-381) might have several helical structures (Fig. 2B) . The helical structures of DED domains seemed to be important in the protein-protein interaction (37, 38) . 
FAF1 Colocalizes with Fas-DISC to the Cytoplasmic
Membrane-It has been previously shown that Fas-DISC is formed in the cytoplasmic membrane via homotypic interactions. Previously, FAF1 has been reported to localize in diverse subcellular positions such as the nucleus, perinuclear cytoplasm, and nucleoli depending on the cell type (28, 30, 31) . We found that FAF1 localized to the cytoplasm in NIH3T3, BOSC23, and HeLa cells known to be less sensitive to Fas-DISC-mediated apoptosis (data not shown). By confocal microscopic analysis using the antibodies against endogenous FAF1 and Fas, respectively, both FAF1 and Fas localized in the cytoplasmic membrane in cells that were not treated with anti-Fas antibody (Fig. 4, A and B) . Then, the localization of Fas and FAF1 was monitored from 1 to 4 h after Fas treatment. As shown in Fig.  4A , clustering of Fas, which agrees with a previous report (39) , and FAF1 was detected after 1 h of Fas stimulation with anti-Fas antibody. After 2 h, almost all cells showed the diffuse pattern of Fas and FAF1 in the cytoplasm (Fig. 4, A and C) .
To test whether Fas-DISC and FAF1 colocalize in cells before and after stimulation of Fas with the agonistic anti-Fas monoclonal antibody, analysis of colocalization was performed by confocal microscopy using antibodies against endogenous FAF1, Fas, FADD, and caspase-8 in Jurkat cells. As shown in Fig. 4 (B and C) , endogenous FAF1, FADD, and caspase-8 completely colocalized with Fas in cells treated and not treated with anti-Fas antibody. PARP was detected in the nucleus as expected. FAF1 interacts with caspase-8 and FADD. The interaction occurs among the DEDID of FAF1 and the DEDs of caspase-8 and of FADD. Apoptotic signal transmissions via homotypic interaction domains such as death domain, death effector domain, caspase recruitment domain, and DED-recruiting domain have been reported (40) . Most of the caspase-8-interacting proteins interact via their DED motifs (21, 40 -42) . However, death effector domain-associated factor and FLASH interact with DED proteins without having a DED (25, 43) . Likewise, FAF1 here is presented as another example of a protein interacting with the DEDs of caspase-8 and FADD without having a typical DED. The DED has a structure composed of six highly conserved ␣-helices. Even if FAF1 does not show significant homology with DED by amino acid sequence analysis, the DEDID of FAF1 has several potential ␣-helices when analyzed by the protein data base (www2.protein.Osakau.ac.jp) like DEDs. Thus, crystal structural analysis of DEDID of FAF1 would be able to provide information regarding its relevance to DED or DED-like domains.
FAF1-DEDID Is Essential for the Mediation of Fas-induced
Recently, FLASH has been reported as a member of Fas-DISC (25) . FLASH contains a DED-recruitment domain that interacts with the DED domains of caspase-8 and FADD, and FLASH is involved in association of FADD and caspase-8 upon Fas stimulation. However, FLASH does not interact with ei- ther full-length Fas or its death domain. Unlike FLASH, FAF1 directly interacts with Fas-DD as well as FADD-and caspase-8-DEDs. FAF1 is much bigger than FADD even though they have similar protein-interacting characteristics. Thus, it is conceivable that FAF1 might play a role as a scaffolding protein that tethers Fas/FADD/caspase-8 signaling modules. Further studies of the interaction profile of FAF1 with other Fas-DISC members such as FLASH will provide us information of the putative role of FAF1 as a scaffold.
Two different mechanisms exist regarding formation of Fas-DISC (26) . In type I cells, Fas-DISC is preformed without Fas activation and enhanced by Fas activation. In type II cells, the DISC is formed upon Fas activation. Thus, Fas-mediated apoptosis rapidly progresses in type I cells (25, 26) . FLASH is only recruited to Fas upon Fas activation in both type I and II cells (25) . In this study, we showed that FAF1 was already interacting with Fas before Fas activation in both type I (data not shown) and type II cells. In addition, the association of FAF1 with Fas was enhanced during cell death signaling upon Fas activation. Thus, these results suggest that FAF1 might serve as an early seed for the fast formation of DISC.
Interaction of FADD and caspase-8 has been reported to occur through homophilic interaction between the DEDs of FADD and caspase-8 (2, 9). The FADD mutant, lacking Nterminal amino acids 1-79 (DED), functions as a dominantnegative inhibitor of Fas-and tumor necrosis factor-mediated apoptosis. In this study, FAF1-⌬DEDID lacking caspase-8 binding domain functioned similarly. The dominant-negative effect of FAF1-⌬DEDID on Fas-induced cell death testifies to the essentiality of DEDID in mediating Fas-induced cell death. FAF1-⌬DEDID corresponds to the FAF1(s), an endogenous short isoform FAF1 in which most of DEDID is deleted (29) . The cDNAs of FAF1(s) have been found both in the human liver and in the HeLa cell cDNA libraries even though the protein has not yet been detected by Western analysis. Thus, FAF1(s), if translated, would be able to function as an endogenous inhibitor against FAF1 in Fas-induced apoptosis.
The FID of FAF1 interacts with Fas (29) , and the DEDID of FAF1 interacts with the DED of caspase-8. In this respect, FAF1 is similar to the adapter protein FADD. Moreover, both FAF1 and FADD have their interacting modules in tandem. It is conceivable that FAF1 exists in Fas-DISC to amplify the aggregation of caspase-8 via a FADD-like mechanism. We expect a cooperative relationship between FADD and FAF1 in the formation of Fas-DISC, because diminution of apoptosis by FAF1 occurred in FADD-deficient Jurkat cells.
